Takeda Oncology | Leading Cancer Treatment Innovation

A person in a lab coat holding a pipette

Decades of Leadership in Oncology

About Takeda Oncology

Recent Oncology News

Takeda Announces Closing of Strategic Partnership with Innovent Biologics for Next-Generation Investigational Oncology Medicines

December 4, 2025

Takeda Unveils Pioneering Advances in Hematologic Cancers and Rare Blood Disorders at the 67th American Society of Hematology (ASH) Annual Meeting

November 3, 2025

Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors

October 21, 2025

European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD

At Takeda, we aspire to cure cancer, with inspiration from patients and innovation from everywhere.

Better Health, Brighter Future

A group of people in lab coats looking through microscopes

Our Medicines

We're committed to advancing treatment options that enhance & extend the lives of people living with cancer.

FIND OUT MORE

A pipette dropping liquid into a test tube

Oncology Pipeline

Our R&D efforts focus on advancing medicines for hematologic, thoracic and gastrointestinal cancers.

FIND OUT MORE

Two people smiling

Patient Advocacy & Support

We're committed to helping people living with cancer navigate their journey – from diagnosis to survivorship.

FIND OUT MORE

Connect with Us

Contact Takeda Oncology for resources, information, or support.